Akt/p27(kip1) Pathway Is Not Involved in Human Insulinoma Tumorigenesis

Insulinomas are pancreatic neuroendocrine tumors (pNET), usually benign. Akt/p27(kip1) is an intracellular pathway overexpressed in many pNET. There are no data regarding its expression in human insulinomas. We aimed to investigate the expression of Akt and p27(kip1) in 24 human insulinomas and to compare them to their expression in normal surrounding islets. Staining was performed on embedded paraffin tissue using polyclonal antibodies against total Akt, p-Akt, p27(kip1), and pp27(kip1). p-Akt was the predominant form in insulinomas; they presented lower Akt and p-Akt expression than normal islets in 83.3% and 87.5% of tumors, respectively. p27(kip1) and pp27(kip1) were mainly cytoplasmic in both insulinomas and normal tissue. Cytoplasmic pp27(kip1) staining was higher in insulinomas and surprisingly nearly half of the insulinomas also presented nuclear p27(kip1) (p = 0.029). No differences were observed in the subcellular localization of p27(kip1) and activation of Akt between benign and malignant insulinomas. The low expression of Akt seen in insulinomas might explain the usual benign behavior of this type of pNET. Cytoplasmic p27(kip1) in both insulinomas and normal islet cells could reflect the low rate of replication of beta cells, while nuclear p27(kip1) would seem to indicate stabilization and nuclear anchoring of the cyclin D-Cdk4 complex. Our data seem to suggest that the Akt pathway is not involved in human insulinoma tumorigenesis.